quinazolines has been researched along with bay 11-7085 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hanakawa, Y; Hashimoto, K; Kagami, S; Kakinuma, T; Komine, M; Tamaki, K | 1 |
Chung, CR; Han, HJ; Kim, SR; Lee, KS; Lee, MH; Lee, YC; Min, KH; Moon, H; Park, SJ; Puri, KD | 1 |
2 other study(ies) available for quinazolines and bay 11-7085
Article | Year |
---|---|
Mechanism of thymus- and activation-regulated chemokine (TARC)/CCL17 production and its modulation by roxithromycin.
Topics: Anti-Bacterial Agents; Cells, Cultured; Chemokine CCL17; Chemokines, CC; ErbB Receptors; Humans; Interferon-gamma; Keratinocytes; NF-kappa B; Nitriles; p38 Mitogen-Activated Protein Kinases; Quinazolines; Roxithromycin; Sesquiterpenes; Signal Transduction; Sulfones; Tumor Necrosis Factor-alpha | 2005 |
Phosphoinositide 3-kinase δ inhibitor suppresses interleukin-17 expression in a murine asthma model.
Topics: Adenine; Animals; Asthma; Bronchoalveolar Lavage Fluid; Chemotactic Factors; Eosinophils; Female; Interleukin-17; Interleukin-4; Interleukin-5; Lung; Lymphocytes; Mice; Mice, Inbred C57BL; Neutrophils; NF-kappa B; Nitriles; Phosphoinositide-3 Kinase Inhibitors; Quinazolines; Sulfones | 2010 |